Ушбу иш иқтибос қилган ишлар

45 та иш

Иш: Data from Silencing Survivin Splice Variant 2B Leads to Antitumor Activity in Taxane-Resistant Ovarian Cancer

Survivin counteracts the therapeutic effect of microtubule de-stabilizers by stabilizing tubulin polymers
Chun Hei Antonio Cheung, Huang-Hui Chen, Ching-Chuan Kuo +4
Мақола20092 иқтибос
ABI
Survivin, cancer networks and pathway-directed drug discovery
Dario C. Altieri
Шарҳ мақола20072 иқтибос
ABI
p27Kip1 Stabilization and G1 Arrest by 1,25-Dihydroxyvitamin D3 in Ovarian Cancer Cells Mediated through Down-regulation of Cyclin E/Cyclin-dependent Kinase 2 and Skp1-Cullin-F-box Protein/Skp2 Ubiquitin Ligase
Pengfei Li, Chunrong Li, Xiuhua Zhao +3
Мақола20042 иқтибос
ABI
Differential subcellular localization of functionally divergent survivin splice variants
Csaba Mahotka, Joerg Liebmann, Michael Wenzel +4
Мақола20022 иқтибос
ABI
The Survivin Isoform Survivin-3B is Cytoprotective and can Function as a Chromosomal Passenger Complex Protein
Shirley K. Knauer, Carolin Bier, P. Schlag +14
Мақола20072 иқтибос
ABI
Induction of Survivin Expression by Taxol (Paclitaxel) Is an Early Event, Which Is Independent of Taxol-mediated G2/M Arrest
Xiang Ling, Ralph J. Bernacki, Michael G. Brattain +1
Мақола20042 иқтибос
ABI
Deconstructing Survivin: comprehensive genetic analysis of Survivin function by conditional knockout in a vertebrate cell line
Zuojun Yue, Ana Xavier Carvalho, Zhenjie Xu +10
Мақола20082 иқтибос
ABI
Survivin Modulates Microtubule Dynamics and Nucleation throughout the Cell Cycle
Jack Rosa, Pedro M. Canovas, Ashraful Islam +2
Мақола20062 иқтибос
ABI
Nuclear and Cytoplasmic Survivin: Molecular Mechanism, Prognostic, and Therapeutic Potential
Roland H. Stauber, Wolf J. Mann, Shirley K. Knauer
Шарҳ мақола20072 иқтибос
ABI
Alternative Splice Variants of Survivin as Potential Targets in Cancer
Janardhan Sampath, Louis M. Pelus, Janardhan Sampath
Шарҳ мақола20072 иқтибос
ABI
Correlation between transcriptional expression of survivin isoforms and clinicopathological findings in human colorectal carcinomas
Keiji Suga, Tetsuhisa Yamamoto, Yoshitaka Yamada +3
Мақола20052 иқтибос
ABI
Cyclin D1 Degradation Is Sufficient to Induce G1 Cell Cycle Arrest despite Constitutive Expression of Cyclin E2 in Ovarian Cancer Cells
Chioniso Patience Masamha, Doris M. Benbrook
Мақола20092 иқтибос
ABI
c-Jun-NH2-kinase-1 Inhibition Leads to Antitumor Activity in Ovarian Cancer
Pablo E. Vivas‐Mejía, Juliana M. Benito, Ariel Fernández +16
Мақола20092 иқтибос
ABI
Mechanism of XIAP-Mediated Inhibition of Caspase-9
Eric N. Shiozaki, Jijie Chai, Daniel J. Rigotti +6
Мақола20032 иқтибос
ABI
Structural basis of IAP recognition by Smac/DIABLO
Geng Wu, Jijie Chai, Tomeka Suber +4
Мақола20002 иқтибос
ABI
Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties.
Csaba Mahotka, Michael Wenzel, Erik Springer +2
Мақола19992 иқтибос
ABI
A role for survivin in chemoresistance of endothelial cells mediated by VEGF
Jennifer M. Tran, Zubin Master, Joanne Yu +3
Мақола20022 иқтибос
ABI
IAP family proteins---suppressors of apoptosis
Quinn L. Deveraux, John C. Reed
Шарҳ мақола19992 иқтибос
ABI
Therapeutic Targeting of ATP7B in Ovarian Carcinoma
Lingegowda S. Mangala, Vesna Zuzel, Rosemarie Schmandt +18
Мақола20092 иқтибос
ABI
Survivin expression in ovarian cancer.
Z Liguang, L Peishu, M Hongluan +4
Мақола20072 иқтибос
ABI